USE OF A DERIVATIVE OF DIHYDROTIENOPYRIDINE FOR THE INHIBITION OF BRAIN RELEASE OF GLUTAMATE.

摘要

THE USE OF ACTIVE INGREDIENT OF METHYL (+) - (4S) -4,7-DIHYDRO3-ISOBUTYL-6-METHYL-4- (3-NITROPHENYL) THENO [2,3-B] PIRIDIN-5CARBOXYLATE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION TO INHIBIT THE RELEASE OF BRAIN GLUTAMATE. THE FORMULATION IS USEFUL IN THE TREATMENT OF EPILEPSY, ALTZHEIMER'S DISEASE AND HUNTINGTON'S KOREA.